Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
The current study was conducted on a sample of 91 patients diagnosed with diastolic dysfunction (DD) with preserved systolic function caused by a painful chronic ischaemic cardiopathy – angina pectoris stable at the effort. The diagnosis was established following anamnesis, electrocardiogram, and ec...
Main Authors: | Bogdan Ioan Coculescu, Gabi Valeriu Dincă, Constantin Bălăeţ, Gheorghe Manole, Maria Bălăeţ, Cristina Mariana Stocheci |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2018.1499626 |
Similar Items
-
Adiponectin – stratification biomarker in diastolic cardiac dysfunction
by: Valeriu-Gabi Dincă, et al.
Published: (2023-12-01) -
Myeloperoxidase (MPO) – possible diagnosis biomarker and risk stratification in myocardial inotropism deficit induced by chronic ischemic heart disease
by: Gabi Valeriu Dinca, et al.
Published: (2022-09-01) -
Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease
by: Bogdan-Ioan Coculescu, et al.
Published: (2019-01-01) -
Relation of Left Ventricular Diastolic Dysfunction to Serum Ferritin in Thalassemia Major
by: Aso Faeq Salih, et al.
Published: (2019-11-01) -
Released Myeloperoxidase Attenuates Neutrophil Migration and Accumulation in Inflamed Tissue
by: Jacob F. Rehring, et al.
Published: (2021-04-01)